About Careers Internship MedBlog Contact us

AstraZeneca Inks Agreement with Roche, Qiagen for New Blood-based Cancer Drug Tests

by Vishnuprasad on July 29, 2014 at 11:16 AM
AstraZeneca Inks Agreement with Roche, Qiagen for New Blood-based Cancer Drug Tests

AstraZeneca has signed an agreement with Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to find out patients who will benefit from its lung cancer drugs.

At present, the testing of patients to see if their tumors contain genetic mutations that make them suitable for drug treatment involves collecting a sample of tissue by needle biopsy or during surgery.


The new tests are based on smart technology that can find out small fragments of circulating tumor DNA in the plasma taken from patients' blood.

The association with Qiagen involves developing such a test to accompany AstraZeneca's established lung cancer pill Iressa, while the collaboration with Roche is for a companion diagnostic to go with AstraZeneca's experimental successor to Iressa called AZD9291.

AZD9291 targets a genetic mutation that helps tumors avoid existing treatments and AstraZeneca believes it could sell a total of $3 billion a year.

The mutation, T790M, develops in about half of lung cancers that become defiant to current epidermal growth factor receptor inhibitors like Iressa.

Source: Medindia
Font : A-A+



Recommended Readings

Latest Drug News

New Inverse Vaccine Sparks Hope in Diabetes, Arthritis, and Crohn's Disease
The reverse vaccine uses the liver's natural "non-target" signals to prevent autoimmune responses against naturally decaying cells.
Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

AstraZeneca Inks Agreement with Roche, Qiagen for New Blood-based Cancer Drug Tests Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests